Wolverine Trading
AGN.PRA

Wolverine Trading’s Allergan plc AGN.PRA Stock Holding History

Wolverine Trading’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-582
Closed -$506K – 5479
2017
Q2 		$506K Sell
582
-204
-26% -$171K ﹤0.01% 2421
2017
Q1 		$669K Buy
+786
New +$651K ﹤0.01% 2086

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Wolverine Trading's AGN.PRA Position: Q3 2017 in Review

Wolverine Trading sold out of Allergan plc (AGN.PRA) in Q3 2017, closing a stake of 582 shares — an estimated $506K sold.

Wolverine Trading first reported a position in AGN.PRA in Q1 2017 and held it in 2 quarters. The position peaked at $669K in Q1 2017. 106 funds tracked by Wall St. Rank hold AGN.PRA as of Q3 2017.

  • Wolverine Trading reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Wolverine Trading sold 582 Allergan plc shares in Q3 2017, an estimated $506K.
  • Wolverine Trading first reported a position in Allergan plc in Q1 2017 and held it in 2 quarters.
  • Wolverine Trading's Allergan plc position peaked at $669K in Q1 2017.
  • 106 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Wolverine Trading's 13F filing for Q3 2017, filed 15 Nov 2017.